tradingkey.logo

Evolent Health Inc

EVH
4.170USD
+0.010+0.24%
Close 01/09, 16:00ETQuotes delayed by 15 min
465.34MMarket Cap
LossP/E TTM

Evolent Health Inc

4.170
+0.010+0.24%

More Details of Evolent Health Inc Company

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

Evolent Health Inc Info

Ticker SymbolEVH
Company nameEvolent Health Inc
IPO dateJun 05, 2015
CEOBlackley (Seth)
Number of employees4500
Security typeOrdinary Share
Fiscal year-endJun 05
Address1812 North Moore St, Suite 1705
CityARLINGTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code22209
Phone15713896000
Websitehttps://www.evolent.com/
Ticker SymbolEVH
IPO dateJun 05, 2015
CEOBlackley (Seth)

Company Executives of Evolent Health Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Seth Blackley
Mr. Seth Blackley
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
508.13K
+67150.00%
Mr. John Paul Johnson
Mr. John Paul Johnson
Chief Strategy Officer
Chief Strategy Officer
184.49K
+25461.00%
Mr. Peter J. Grua
Mr. Peter J. Grua
Independent Director
Independent Director
82.65K
+21979.00%
Mr. Richard M. Jelinek
Mr. Richard M. Jelinek
Independent Chairman of the Board
Independent Chairman of the Board
66.44K
+21979.00%
Ms. Kim Keck
Ms. Kim Keck
Independent Director
Independent Director
61.50K
+21979.00%
Mr. Aammaad Shams
Mr. Aammaad Shams
Chief Accounting Officer
Chief Accounting Officer
55.40K
-2567.00%
Mr. Craig A. Barbarosh
Mr. Craig A. Barbarosh
Independent Director
Independent Director
53.94K
+21979.00%
Dr. Toyin Ajayi, M.D.
Dr. Toyin Ajayi, M.D.
Independent Director
Independent Director
34.07K
+21979.00%
Mr. Shawn M. Guertin
Mr. Shawn M. Guertin
Director
Director
21.98K
+21979.00%
Mr. Jonathan D. Weinberg, J.D.
Mr. Jonathan D. Weinberg, J.D.
General Counsel
General Counsel
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Seth Blackley
Mr. Seth Blackley
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
508.13K
+67150.00%
Mr. John Paul Johnson
Mr. John Paul Johnson
Chief Strategy Officer
Chief Strategy Officer
184.49K
+25461.00%
Mr. Peter J. Grua
Mr. Peter J. Grua
Independent Director
Independent Director
82.65K
+21979.00%
Mr. Richard M. Jelinek
Mr. Richard M. Jelinek
Independent Chairman of the Board
Independent Chairman of the Board
66.44K
+21979.00%
Ms. Kim Keck
Ms. Kim Keck
Independent Director
Independent Director
61.50K
+21979.00%
Mr. Aammaad Shams
Mr. Aammaad Shams
Chief Accounting Officer
Chief Accounting Officer
55.40K
-2567.00%

Revenue Breakdown

Currency: USDUpdated: Mon, Feb 24
Currency: USDUpdated: Mon, Feb 24
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Platform and operations
896.75M
98.77%
Transformation services
11.20M
1.23%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Platform and operations
896.75M
98.77%
Transformation services
11.20M
1.23%

Shareholding Stats

Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cadian Capital Management LP
10.51%
The Vanguard Group, Inc.
9.81%
BlackRock Institutional Trust Company, N.A.
7.04%
Fidelity Management & Research Company LLC
6.88%
Morgan Stanley & Co. LLC
6.71%
Other
59.05%
Shareholders
Shareholders
Proportion
Cadian Capital Management LP
10.51%
The Vanguard Group, Inc.
9.81%
BlackRock Institutional Trust Company, N.A.
7.04%
Fidelity Management & Research Company LLC
6.88%
Morgan Stanley & Co. LLC
6.71%
Other
59.05%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.16%
Hedge Fund
33.00%
Investment Advisor/Hedge Fund
25.86%
Research Firm
11.11%
Individual Investor
1.68%
Venture Capital
0.61%
Pension Fund
0.60%
Bank and Trust
0.43%
Sovereign Wealth Fund
0.16%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
587
138.53M
124.13%
-22.10M
2025Q3
584
129.76M
138.30%
+2.04M
2025Q2
592
127.73M
134.03%
-821.05K
2025Q1
600
129.09M
124.35%
-14.98M
2024Q4
595
125.09M
125.40%
-8.52M
2024Q3
581
135.11M
127.13%
-2.01M
2024Q2
548
133.70M
119.87%
+3.78M
2024Q1
540
129.73M
121.95%
-10.10M
2023Q4
532
130.59M
118.36%
+3.98M
2023Q3
522
126.08M
116.67%
+4.88M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Cadian Capital Management LP
11.73M
10.51%
+1.30M
+12.51%
Sep 30, 2025
The Vanguard Group, Inc.
10.95M
9.81%
+45.30K
+0.42%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
7.85M
7.04%
+105.25K
+1.36%
Sep 30, 2025
Fidelity Management & Research Company LLC
7.68M
6.88%
+1.31M
+20.55%
Sep 30, 2025
Morgan Stanley & Co. LLC
7.49M
6.71%
+132.69K
+1.80%
Sep 30, 2025
Eventide Asset Management, LLC
6.29M
5.64%
+2.21M
+53.97%
Sep 30, 2025
Rubicon Founders, LLC
5.82M
5.21%
--
--
Nov 13, 2025
Engaged Capital, LLC
5.66M
5.08%
-190.56K
-3.25%
Sep 30, 2025
William Blair Investment Management, LLC
4.04M
3.62%
-289.41K
-6.69%
Sep 30, 2025
UBS Financial Services, Inc.
3.40M
3.05%
+590.66K
+21.01%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
0.59%
Optimize Strategy Index ETF
0.15%
iShares U.S. Healthcare Providers ETF
0.12%
JPMorgan Fundamental Data Science Small Core ETF
0.1%
Avantis US Small Cap Equity ETF
0.07%
State Street SPDR S&P Kensho New Econ Comp ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.04%
Strive Small-Cap ETF
0.04%
Global X Russell 2000 ETF
0.03%
View more
Global X HealthTech ETF
Proportion0.59%
Optimize Strategy Index ETF
Proportion0.15%
iShares U.S. Healthcare Providers ETF
Proportion0.12%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.1%
Avantis US Small Cap Equity ETF
Proportion0.07%
State Street SPDR S&P Kensho New Econ Comp ETF
Proportion0.06%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.04%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion0.04%
Strive Small-Cap ETF
Proportion0.04%
Global X Russell 2000 ETF
Proportion0.03%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Evolent Health Inc?

The top five shareholders of Evolent Health Inc are:
Cadian Capital Management LP holds 11.73M shares, accounting for 10.51% of the total shares.
The Vanguard Group, Inc. holds 10.95M shares, accounting for 9.81% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 7.85M shares, accounting for 7.04% of the total shares.
Fidelity Management & Research Company LLC holds 7.68M shares, accounting for 6.88% of the total shares.
Morgan Stanley & Co. LLC holds 7.49M shares, accounting for 6.71% of the total shares.

What are the top three shareholder types of Evolent Health Inc?

The top three shareholder types of Evolent Health Inc are:
Cadian Capital Management LP
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.

How many institutions hold shares of Evolent Health Inc (EVH)?

As of 2025Q4, 587 institutions hold shares of Evolent Health Inc, with a combined market value of approximately 138.53M, accounting for 124.13% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -14.18%.

What is the biggest source of revenue for Evolent Health Inc?

In FY2021, the Platform and operations business generated the highest revenue for Evolent Health Inc, amounting to 896.75M and accounting for 98.77% of total revenue.
KeyAI